Morgan Stanley finds that OpenAI's revenue contribution to Microsoft Azure over the next few years now appears on track to be ...

Morgan Stanley analysts predict that, despite recent dovish comments from officials, the Fed is unlikely to cut interest ...

Ellen Zenter, Morgan Stanley Wealth Management chief economic strategist, joins CNBC's 'Power Lunch' to discuss market ...

Vistra Corp. (NYSE:VST) is one of the 10 best AI stocks to buy according to billionaire David Tepper. On June 19, Morgan ...

Shares of Morgan Stanley MS rallied 1.47% to $139.75 Thursday, on what proved to be an all-around favorable trading session ...

Middle-market focused Morgan Stanley Capital Partners has collected $3.2 billion for its latest buyout fund amid a tough ...

Morgan Stanley's bear case for the S&P 500 involves oil prices spiking significantly amid conflict in the Middle East, ...

Strategists led by Michael Wilson say in a new research note published Monday that periods of volatility similar to the ...

Morgan Stanley raised the firm’s price target on BeOne Medicines (ONC) to $330 from $313 and keeps an Overweight rating on the shares following the R&D day that highlighted the company’s pipeline ...

Morgan Stanley (MS) closed seventh session of gains on Friday as its shares ended 0.67% higher at $140.69. In the preceding six sessions, the company’s shares g ...

The global brokerage expects a strong growth data, supportive moves by the RBI, and better-than-expected corporate earnings ...

The analyst further reasoned that Salesforce, Inc. (NYSE:CRM) has a promising product portfolio that includes GenAI solutions ...